The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Lonza Biologics competitive analysis

Loading summary...

Latest patents of Lonza Biologics opposed by its competitors

Explore Lonza Biologics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP1915394
Jan 27, 2021High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell6
EP2467400
Jan 24, 2018Variant Immunoglobulins With Improved Manufacturability2

Latest PTAB cases involving Lonza Biologics

Discover the latest PTAB cases involving Lonza Biologics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Lonza Biologics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LONZA BIOLOGICS - 8 - -
EUROPEAN OPPOSITIONS30 - - -
LASAR2 - - -
MAIWALD136 - - -